Economic Impact of Home INR Monitoring
Home INR Monitoring can have a positive economic impact when combined with in-office point-of-care testing.
Many factors can affect the economic impact that in-office point-of-care testing and patient self-testing may have on your practice:
- Schedule of regular in-office visits to augment home monitoring
- Prescribed frequency of testing at home
- Establishing an efficient process for managing out-of-range results in-office
- Length of time to manage patients during intervention
- Management protocols for results reporting of home monitoring
Home INR Monitoring complements routine clinician care
There are no costs to the practice when prescribing Home INR Monitoring to your patients. The program is designed to augment, not replace regularly scheduled office visits. This means that the fees associated with your patient’s regular office visits will not necessarily be impacted.
Reimbursable for physicians1
Medicare and many private insurers reimburse physicians for a separate CPT code (G0250) for the review and interpretation of test results performed by patients at home. Depending upon the training method selected, there is also reimbursement (G0248) available for initial training on the INR monitor.
For additional reimbursement support, look up CPT® & ICD-9codes, coverage policies, and state by state Medicare reimbursement information go to www.codemap.com/alere. Or contact the CodeMap® Hotline at 847.381.5465, ext 5.
Manage your anticoagulation patients at your fingertips.
The web-based Alere CoagClinic® decision support application allows you to keep track of INR results, dosing and more – anytime, anywhere.
Call Alere at 1.866.408.1205 to talk to an associate today!